Suppr超能文献

用组胺H1和H2受体拮抗剂治疗的系统性肥大细胞增多症。

Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists.

作者信息

Gasior-Chrzan B, Falk E S

机构信息

Department of Dermatology, University of Tromsø, Norway.

出版信息

Dermatology. 1992;184(2):149-52. doi: 10.1159/000247526.

Abstract

A case of systemic mastocytosis with skin characteristics of telangiectasia macularis eruptiva perstans is reported. Systemic involvement was confirmed as a combination of highly increased urinary excretion of methyl imidazole acetic acid (Melm AA) and increased amounts of mast cells in skin, liver and colon transversum. Treatment with cimetidine (H2 receptor antagonist) resulted in diarrhea, however, the addition of cyproheptadine (H1 receptor antagonist) was beneficial in amelioration of the cutaneous symptoms of mastocytosis. The excretion of Melm AA was unchanged during treatment. After 7 months of continuous cimetidine and cyproheptadine treatment no side effects were observed.

摘要

报告了一例具有持久性斑疹性毛细血管扩张皮肤特征的系统性肥大细胞增多症病例。通过甲基咪唑乙酸(Melm AA)尿排泄量大幅增加以及皮肤、肝脏和横结肠中肥大细胞数量增多相结合,证实存在全身受累情况。用西咪替丁(H2受体拮抗剂)治疗导致腹泻,然而,添加赛庚啶(H1受体拮抗剂)有助于改善肥大细胞增多症的皮肤症状。治疗期间Melm AA的排泄量未变。连续使用西咪替丁和赛庚啶治疗7个月后未观察到副作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验